(1S,3S)-methyl 1-(4-fluorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate | 238428-10-9

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 哈马拉生物碱
• 英文名称: (1S,3S)-methyl 1-(4-fluorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate
• 英文别名: methyl (1S,3S)-1-(4-fluorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate
• CAS: 238428-10-9
• 化学式: C₁₉H₁₇FN₂O₂
• 分子量: 324.355
• InChiKey: JIQYBJXVKDJNDY-IRXDYDNUSA-N

物化性质

• 沸点：
  487.0±45.0 °C(Predicted)
• 密度：
  1.293±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  24
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  54.1
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (1S,3S)-methyl 1-(4-fluorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate 在 三甲胺 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 反应 0.5h， 生成 (5S,11aR)-2-(2-fluorophenyl)-5-(4-fluorophenyl)-5,6,11,11a-tetrahydro-1H-imidazo[1′,5′:1,6]pyrido[3,4-b]indole-1,3(2H)-dione
  参考文献：
  名称：

  基于β-Carboline的拮抗剂探索TRPM8结合位点及其体外表征和体内止痛活性。

  摘要：

  瞬时受体电位褪黑素8（TRPM8）离子通道代表了几个治疗领域的宝贵药理学选择。在此，制备了先前描述的TRPM8拮抗剂N，N′-二苄基色氨酸4的一系列构象受限的衍生物，并通过Ca 2+成像和膜片钳电生理测定体外表征。分子建模研究导致在TRPM8结合位点内确定了这些衍生物的广泛且明确定义的相互作用网络，这是其拮抗剂活性的基础。（5 R，11a S）-5-（4-氯苯基）-2-（4-氟苄基）-5,6,11,11a-四氢-1 H-咪唑[1'，5'：1,6]吡啶[3,4-b ]吲哚-1,3（2 H）-二酮（31a）以有效的（IC 50 = 4.10±1.2 nM），选择性且代谢稳定的TRPM8拮抗剂出现。在体内，31a在icilin诱导的WDS（11.5 mg / kg ip），奥沙利铂诱导的冷异常性疼痛（10-30μgsc）和CCI诱导的热痛觉过敏（11.5 mg / kg）中显示出显着的靶标覆盖范围。

  DOI：

  10.1021/acs.jmedchem.0c00816
• 作为产物：
  描述：

  L-色氨酸 在 氯化亚砜 、 sodium carbonate 作用下， 以 甲醇 为溶剂， 生成 (1S,3S)-methyl 1-(4-fluorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate
  参考文献：
  名称：

  Potent 1,3-disubstituted-9H-pyrido[3,4-b]indoles as new lead compounds in antifilarial chemotherapy1CDRI Communication No. 5795.1

  摘要：

  Substituted 9H-pyrido[3,4-b]indoles (beta-carbolines) identified in our laboratory as potential pharmacophore for designing macrofilaricidal agents, have been explored further for identifying the pharmacophore responsible for high order of adulticidal activity. This has led to syntheses and macrofilaricidal evaluations of a number of 1-aryl-9H-pyrido[3,4-b]indole-3-carboxyl derivatives (3-7). The macrofilarical activity was initially evaluated in vivo against Acanthoeilonema viteae. Amongst all the synthesized compounds, only twelve compounds namely 3a, 3c, 3d, 3f, 4c, 4d, 4f, 5a, 6f, 6h, 6i and 7h have exhibited either > 90% micro- or macrofilaricidal activity or sterilization of female worms. These compounds have also been screened against Litomosoides carinii and of these only 3f and 5a have also been found to be active. Finally these two compounds have been evaluated against Brugia malayi. The structure activity relationship (SAR) associated with position-1 and 3 substituents in beta-carbolines have been discussed. It has been observed that the presence of carbomethoxy at position-3 and an aryl substituent at position-1 in beta-carbolines effectively enhance antifilarial activity particularly against A. viteae. Amongst the various compounds screened, methyl 1-(4-methylphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate (4c) has shown highest adulticidal activity and methyl 1-(4-chlorophenyl)1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole-3-carboxylate (3a) has shown highest microfilaricidal action against A. viteae at 50mg/ kgx5 days (ip). Another derivative of this compound namely 1-(4-chlorophenyl)-3-hydroxymethyl-9H-pyrido[3,4-b]indole (5a) exhibited highest activity against L. carinii at 30 mg/kg x 5 days (ip) and against B. malayi at 50 mg/kg x 5 days (ip) or at 200 mg/ kgx5 days (po). (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(99)00050-4

文献信息

• DNA-binding affinity and anticancer activity of β-carboline–chalcone conjugates as potential DNA intercalators: Molecular modelling and synthesis
  作者：Nagula Shankaraiah、K.P. Siraj、Shalini Nekkanti、Vunnam Srinivasulu、Pankaj Sharma、Kishna Ram Senwar、Manda Sathish、M.V.P.S. Vishnuvardhan、Sistla Ramakrishna、Chetna Jadala、Narayana Nagesh、Ahmed Kamal

  DOI：10.1016/j.bioorg.2015.02.007

  日期：2015.4

  A new series of DNA-interactive beta-carboline-chalcone conjugates have been synthesized and evaluated for their in vitro cytotoxicity and DNA-binding affinity. It has been observed that most of these new hybrids have shown potent cytotoxic activities on A-549 ( lung adenocarcinoma) cell lines with IC50 values lower than 10 mu M. The hybrid 7b is more effective against some of the selected cancer cell lines with IC50 values less than 50 mu M. In addition, compounds 7e, 7k, 7p-u has displayed significant elevation in Delta T-m of DNA in comparison to Adriamycin, suggesting significant interaction and remarkable DNA stabilization. The DNA intercalation of these new hybrids has been investigated by fluorescence titration, DNA viscosity measurements, molecular docking as well as molecular dynamics and the results are in agreement with the thermal denaturation studies. (C) 2015 Elsevier Inc. All rights reserved.
• Highly stereoselective transformation of (1S,3S)-cis-1,3-disubstituted tetrahydro-β-carbolines into (1S,3R)-trans-1,3-disubstituted tetrahydro-β-carbolines: an improved asymmetric synthesis of tadalafil from l-tryptophan
  作者：Jing Dong、Tian-Zhuo Meng、Xiao-Xin Shi、Wen-Hui Zou、Xia Lu

  DOI：10.1016/j.tetasy.2013.06.006

  日期：2013.8

  An efficient and general method for the highly stereoselective transformation of (1S,3S)-cis-1,3-disubstituted 1,2,3,4-tetrahydro-beta-carbolines (THBCs) into (15,3R)-trans-1,3-disubstituted THBCs is described. The method contains the following three steps: the enantiomerically pure (1S,3S)-cis-1,3-disubstituted THBCs 1 were first converted into (1S,3S)-cis-1,2,3-trisubstituted THBCs 2 by N-1-naphthylmethylation/benzylation; (15,3S)-cis-1,2,3-trisubstituted THBCs 2 were then converted into (1S,3R)-trans-1,2,3-trisubstituted THBCs 3 in high yields and with high stereoselectivities via a base-catalyzed epimerization at C-3; (1S,3R)-trans-1,2,3-trisubstituted THBCs 3 were subsequently converted into (15,3R)-trans-1,3-disubstituted THBCs 4 after reductive removal of the 1-naphthylmethyl/benzyl group. In addition, as an application of this method, an improved and highly stereoselective synthesis of the PDE5 inhibitor tadalafil (Cialis (R)) starting from natural and less expensive L-tryptophan was developed. (C) 2013 Elsevier Ltd. All rights reserved.
• Target-Agnostic P-Glycoprotein Assessment Yields Strategies to Evade Efflux, Leading to a BRAF Inhibitor with Intracranial Efficacy
  作者：Aya M. Kelly、Matthew R. Berry、Sarah Z. Tasker、Sydney A. McKee、Timothy M. Fan、Paul J. Hergenrother

  DOI：10.1021/jacs.2c03944

  日期：2022.7.13
• [EN] COMPOSITIONS AND FORMULATIONS OF METHYLERTHRITOL PHOSPHATE PATHWAY INHIBITORS AND USES THEREOF<br/>[FR] COMPOSITIONS ET FORMULATIONS D'INHIBITEURS DE LA VOIE MÉTHYLERTHRITOL PHOSPHATE ET LEURS UTILISATIONS
  申请人：VIRGINIA TECH INTELL PROP

  公开号：WO2016069949A1

  公开（公告）日：2016-05-06

  Described herein are compounds and formulations thereof that can inhibit the methylerythritol phosphate pathway (MEP). Also described herein are methods of making and uses of the compounds and formulations thereof described herein.
• Exploration of TRPM8 Binding Sites by β-Carboline-Based Antagonists and Their In Vitro Characterization and In Vivo Analgesic Activities
  作者：Alessia Bertamino、Carmine Ostacolo、Alicia Medina、Veronica Di Sarno、Gianluigi Lauro、Tania Ciaglia、Vincenzo Vestuto、Giacomo Pepe、Manuela Giovanna Basilicata、Simona Musella、Gerardina Smaldone、Claudia Cristiano、Sara Gonzalez-Rodriguez、Asia Fernandez-Carvajal、Giuseppe Bifulco、Pietro Campiglia、Isabel Gomez-Monterrey、Roberto Russo

  DOI：10.1021/acs.jmedchem.0c00816

  日期：2020.9.10

  Transient receptor potential melastatin 8 (TRPM8) ion channel represents a valuable pharmacological option for several therapeutic areas. Here, a series of conformationally restricted derivatives of the previously described TRPM8 antagonist N,N′-dibenzyl tryptophan 4 were prepared and characterized in vitro by Ca2+-imaging and patch-clamp electrophysiology assays. Molecular modeling studies led to

  瞬时受体电位褪黑素8（TRPM8）离子通道代表了几个治疗领域的宝贵药理学选择。在此，制备了先前描述的TRPM8拮抗剂N，N′-二苄基色氨酸4的一系列构象受限的衍生物，并通过Ca 2+成像和膜片钳电生理测定体外表征。分子建模研究导致在TRPM8结合位点内确定了这些衍生物的广泛且明确定义的相互作用网络，这是其拮抗剂活性的基础。（5 R，11a S）-5-（4-氯苯基）-2-（4-氟苄基）-5,6,11,11a-四氢-1 H-咪唑[1'，5'：1,6]吡啶[3,4-b ]吲哚-1,3（2 H）-二酮（31a）以有效的（IC 50 = 4.10±1.2 nM），选择性且代谢稳定的TRPM8拮抗剂出现。在体内，31a在icilin诱导的WDS（11.5 mg / kg ip），奥沙利铂诱导的冷异常性疼痛（10-30μgsc）和CCI诱导的热痛觉过敏（11.5 mg / kg）中显示出显着的靶标覆盖范围。